Table 3

CT and procedural characteristics and their association with permanent pacemaker insertion following TAVI

Q1/referenceQ3/riskOR (95% CI)P value
Aortic root rotation (°)2.0519.250.92 (0.61 to 1.39)0.69
Aortic root qualificationcentral/counterclockwiseclockwise0.80 (0.38 to 1.70)0.57
Aortic root wedging (mm)37.7847.190.92 (0.58 to 1.46)0.72
Frontal aortic root tilt angle (°)42.2053.731.01 (0.67 to 1.51)0.97
Left ventricle to aortic root angle: three-chamber plane (°)122.45133.700.85 (0.54 to 1.34)0.48
Membranous septum height (mm)3.185.200.91 (0.60 to 1.38)0.66
Membranous septum width (mm)4.708.600.92 (0.56 to 1.51)0.76
Membranous septum area (mm)11.5034.710.86 (0.51 to 1.45)0.57
Inferior distance (mm)1.504.400.84 (0.51 to 1.38)0.50
Valve implantation depth (mm)3.837.401.62 (1.01 to 2.61)0.05
Δ Inferior distance to implantation depth (mm)−5.06−0.590.61 (0.38 to 0.99)0.05
Valve oversizing (%)4.2319.551.19 (0.73 to 1.94)0.48
Self/mechanical-expandable versus balloon-expandable valvesBalloonSelf/mechanical2.35 (1.13 to 4.87)0.02
Valve type
 BostonEdwardsBoston4.51 (1.75 to 11.56)0.01
 MedtronicEdwardsMedtronic1.73 (0.78 to 3.87)
  • OR and 95% CI estimated from logistic regression. OR for a comparison of the IQR (Q3 vs Q1). P value for the Wald test.

  • Q1, quartile 1 (25th percentile);Q3, quartile 3 (75th percentile);TAVI, transcatheter aortic valve implantation; Inferior distance, virtual basal ring to muscular ventricular septum height; Δ inferior distance to implantation depth, difference between inferior distance and valve implantation depth.